1. Home
  2. PTGX vs SONO Comparison

PTGX vs SONO Comparison

Compare PTGX & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$139.08

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Logo Sonos Inc.

SONO

Sonos Inc.

N/A

Current Price

$17.75

Market Cap

1.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
PTGX
SONO
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
1.8B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
PTGX
SONO
Price
$139.08
$17.75
Analyst Decision
Strong Buy
Buy
Analyst Count
13
4
Target Price
★ $174.69
$18.63
AVG Volume (30 Days)
535.2K
★ 1.6M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.35
0.77
Revenue
N/A
★ $1,443,276,000.00
Revenue This Year
$1,078.44
$6.89
Revenue Next Year
N/A
$5.65
P/E Ratio
$60.03
★ $23.06
Revenue Growth
★ N/A
N/A
52 Week Low
$62.24
$12.44
52 Week High
$160.81
$19.82

Technical Indicators

Market Signals
Indicator
PTGX
SONO
Relative Strength Index (RSI) 44.31 64.88
Support Level $132.37 $14.11
Resistance Level $142.20 $18.66
Average True Range (ATR) 4.59 0.57
MACD -0.44 0.20
Stochastic Oscillator 39.61 88.73

Price Performance

Historical Comparison
PTGX
SONO

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

Share on Social Networks: